National Commission on Scleroderma and Fibrotic Diseases Act of 2019
United States116th CongressHR-3446House of Representatives
Updated: Jun 25, 2019
Summary
National Commission on Scleroderma and Fibrotic Diseases Act of 2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
Bill texts
All available records shown.
Timeline
Latest companion bill action
S-2477: National Commission on Scleroderma and Fibrotic Diseases Act of 2019Introduced in Senate
Referred to the House Committee on Energy and Commerce.
House of Representatives
Introduced in House
Referred to the Subcommittee on Health.
House of Representatives
All available records shown.